AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma
Strecker, M.I., Wlotzka, K., Strassheimer, F., Roller, B., Ludmirski, G., König, S., Röder, J., Opitz, C., Alekseeva, T., Reul, J., Sevenich, L., Tonn, T., Wels, W.S., Steinbach, J.P., Buchholz, C.J., Burger, M.C.
Published in Oncoimmunology (31.12.2022)
Published in Oncoimmunology (31.12.2022)
Get full text
Journal Article
P06.10.A CAR-ENGINEERED PRIMARY NK CELLS SHOW PROMISING EFFECTS AS TARGETED THERAPY AGAINST EGFR-POSITIVE GLIOBLASTOMA
Roller, B, Reindl, L M, Strassheimer, F, Ludmirski, G, Elleringmann, P, Kiefer, A, Röder, J, Steinbach, J P, Wels, W S, Ullrich, E, Burger, M C
Published in Neuro-oncology (Charlottesville, Va.) (08.09.2023)
Published in Neuro-oncology (Charlottesville, Va.) (08.09.2023)
Get full text
Journal Article
KS05.5.A REPETITIVE INTRACRANIAL INJECTION OF NATURAL KILLER CELLS ENGINEERED WITH A HER2-TARGETED CHIMERIC ANTIGEN RECEPTOR ALONE AND IN COMBINATION WITH SYSTEMIC ANTI-PD-1 CHECKPOINT INHIBITION IN PATIENTS WITH RECURRENT GLIOBLASTOMA
Burger, M C, Ehrend, E, Straßheimer, F, Cakmak, P, Krenzlin, H, Elleringmann, P, Zeiner, P S, Herkt, S C, Poschke, I, Macas, J, Weber, K J, Schupp, J, Lun, J H, Opitz, C, Roller, B, Manns, P, Klinsing, S, Breuer, S, Hehlgans, S, Lee, S, Mildenberger, I C, Ludmirski, G, Hermann, J, Müller, E, Schmitz, M, Mehlitz, M, Senft, C, Harter, P N, Rieger, M A, Rödel, F, Czabanka, M, Ratliff, M, Platten, M, Herold-Mende, C, Ringel, F, Herrmann, E, Hattingen, E, Reiss, Y, Bunse, L, Bonig, H, Plate, K H, Forster, M, Tonn, T, Wels, W S, Steinbach, J P
Published in Neuro-oncology (Charlottesville, Va.) (17.10.2024)
Published in Neuro-oncology (Charlottesville, Va.) (17.10.2024)
Get full text
Journal Article